Management of Pilonidal Sinus Disease with Lyopreserved Umbilical Tissue Allograft Placement: A Case Series

    March 2024 in “ Authorea (Authorea)
    Michael Romberg, Kevin Smit, Jaideep Banerjee
    Image of study
    TLDR Using lyopreserved umbilical tissue allograft may improve healing and reduce recurrence of pilonidal cysts.
    This retrospective case series explores the use of STRAVIX PL, a lyopreserved umbilical tissue allograft, for managing recurrent pilonidal cyst wounds. Pilonidal cysts, which affect approximately 70,000 patients annually in the US, are characterized by inflamed tissue and recurrent infections, often requiring surgical intervention. Traditional treatments like incision and drainage or surgical excision have high recurrence rates and can cause significant discomfort. STRAVIX PL, which retains native components such as extracellular matrix and growth factors, offers a promising alternative due to its durability, ease of application, and potential to reduce recurrence rates. The study suggests that STRAVIX PL may improve wound closure rates and patient outcomes in high-risk surgical procedures.
    Discuss this study in the Community →